Edgewise Therapeutics, Inc. EWTX Market capitalization

Market capitalization at other companies

Bristol-Myers SquibbBMY

$117.66B+22.9%

Sarepta Therapeutics, Inc.SRPT

$1.9B+1.7%

CytokineticsCYTK

$11.57B+190%

PTC TherapeuticsPTCT

$5.64B+40.3%

Dyne Therapeutics, Inc.DYN

$2.99B+153%

Solid Biosciences Inc.SLDB

$983.51M+161%

FAQ

What is Edgewise Therapeutics, Inc.'s market capitalization?

Edgewise Therapeutics, Inc. (EWTX) reported market capitalization of $3.38B in Q1 2026.

How has Edgewise Therapeutics, Inc.'s market capitalization changed year-over-year?

Edgewise Therapeutics, Inc.'s market capitalization increased by 61.3% year-over-year, from $2.09B to $3.38B.

What is the long-term trend for Edgewise Therapeutics, Inc.'s market capitalization?

Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s market capitalization has grown at a 36.5% compound annual growth rate (CAGR), from $757.04M to $2.63B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.